Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis

Chi Qi, Yue Chen and Lin Qiu
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242255;
Chi Qi
1affliated hospital of Southwest Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Chen
2The Affiliated Hospital of Southwest Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Qiu
3Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 65 no. supplement 2 242255

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.

Copyright & Usage 
© 2024

Author Information

  1. Chi Qi1,
  2. Yue Chen2 and
  3. Lin Qiu3
  1. 1affliated hospital of Southwest Medical University
  2. 2The Affiliated Hospital of Southwest Medical University
  3. 3Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20242800
Jul 20244600
Aug 20245700
Sep 20243000
Oct 20245300
Nov 20244500
Dec 20242900
Jan 20251700
Feb 20251900
Mar 20251700
Apr 20252400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis
Chi Qi, Yue Chen, Lin Qiu
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242255;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis
Chi Qi, Yue Chen, Lin Qiu
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242255;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Impact of dual tracer study to differentiate malignant vs benign peritoneal diseases.
  • Initial Clinical Experience with 177Lu-EB-FAPI Radioligand Therapy in Patients with End-Stage Metastatic Cancers
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire